1832 Asset Management L.P. Acadia Pharmaceuticals Inc Transaction History

1832 Asset Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $2.09 Million - $2.81 Million	-53,300 Closed	0 $0
Q1 2020 May 26, 2020	BUY	$31.65 - $46.87 $1.69 Million - $2.5 Million	53,300 New	53,300 $2.22 Million
Q1 2020 May 14, 2020	SELL	$31.65 - $46.87 $1.21 Million - $1.79 Million	-38,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $1.38 Million - $1.96 Million	38,200 New	38,200 $1.66 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.